Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study-Reference-Cited by-同舟云学术

Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

Published:2018-07-18 Issue:9 Volume:19 Page:605-618
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Hatleberg CI¹^ORCID,Ryom L¹^ORCID,d'Arminio Monforte A²,Fontas E³,Reiss P⁴,Kirk O¹,El-Sadr W⁵,Phillips A⁶,de Wit S⁷,Dabis F⁸,Weber R⁹,Law M¹⁰,Lundgren JD¹,Sabin C⁶,

Affiliation:

1. Centre of Excellence for Health; Immunity and Infections; Department of Infectious Diseases Section 2100; Finsencentret; Rigshospitalet; University of Copenhagen; Copenhagen Denmark

2. Department of Health Sciences; Clinic of Infectious and Tropical Diseases; San Paolo University Hospital; Milan Italy

3. Department of Public Health; Nice University Hospital; Nice France

4. Academic Medical Center; Department of Global Health and Division of Infectious Diseases; HIV Monitoring Foundation; University of Amsterdam; Amsterdam the Netherlands

5. International Center for AIDS Care and Treatment Programs (ICAP); Harlem Hospital; Columbia University; New York NY USA

6. Insititute for Global Health; University College London; London UK

7. Division of Infectious Diseases; Saint Pierre University Hospital; Université Libre de Bruxelles; Brussels Belgium

8. Bordeaux Hospital University Centre (CHU) and INSERM U897; University of Bordeaux; Talence France

9. Division of Infectious Diseases and Hospital Epidemiology; University Hospital Zurich; University of Zurich; Zurich Switzerland

10. Kirby Institute; University of New South Wales; Sydney Australia

Funder

Stiching HIV Monitoring (ATHENA)

The Highly Active Antiretroviral Therapy Oversight Committee (HAARTOC)

Barcelona Antiretroviral Surveillance Study (BASS)

Danmarks Grundforskningsfond

Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)

The Italian Cohort Naive to Antiretrovirals (The ICONA Foundation

AbbVie

Bristol-Myers Squibb

Gilead Sciences

ViiV Healthcare

Merck

Janssen Pharmaceuticals

Ministerie van Volksgezondheid, Welzijn en Sport

Agence Nationale de Recherches sur le Sida et les Hépatites Virales

The Australian HIV Observational Database (AHOD)

National Institute of Allergy and Infectious Diseases

Merck Sharp and Dohme

Boehringer Ingelheim

Janssen-Cilag

The Australian Government Department of Health and Ageing

Faculty of Medicine

Fondo de Investigación Sanitaria

Fundación para la Investigación y la Prevención del Sida en España

National Institutes of Health

European Union's Seventh Framework Programme for research, technological development and demonstration under EuroCoord

Pfizer

GlaxoSmithKline

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Swiss HIV Cohort Study

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hiv.12639/fullpdf

Reference40 articles.

1. Changes in causes of death among adults infected by HIV between 2000 and 2005: the “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic);Lewden;JAIDS,2008

2. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration;Smith;Lancet,2014

3. Risk of coronary heart disease in patients with HIV infection;Zanni;Nat Rev Cardiol,2014

5. Renal impairment and cardiovascular disease in HIV-positive individuals: the D:A: D Study;Ryom;J Infect Dis,2016

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis;PLOS ONE;2024-01-29

2. Prevalence and control of hypertension in a high HIV-prevalence setting, insights from a population based study in Botswana;Scientific Reports;2023-10-19

3. Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial;Clinical Infectious Diseases;2023-05-19

4. Hypertension in people living with HIV on combined antiretroviral therapy in rural Tanzania;African Health Sciences;2023-04-06

5. Inflammation markers and the risk of hypertension in people living with HIV;Frontiers in Immunology;2023-03-21